(Q53899946)

English

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

type-1 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

P D Home

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

A Lindholm

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

A Riis

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

European Insulin Aspart Study Group

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

17

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

11

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

762-770

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Intensive insulin therapy for treatment of type I diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Optimization of evening insulin dose in patients using the short-acting insulin analog lispro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

The Effect of the Insulin Analog Lispro on Nighttime Blood Glucose Control in Type 1 Diabetic Patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Monomeric insulins obtained by protein engineering and their medical implications

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00380.X

21 January 2018

Identifiers

10.1046/J.1464-5491.2000.00380.X

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/11131100

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53899946&oldid=1232576938"